{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:57:02Z","timestamp":1648835822654},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T00:00:00Z","timestamp":1477612800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40792-016-0246-2","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T19:25:29Z","timestamp":1477596329000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spontaneous resolution of de novo hepatitis B after living donor liver transplantation with hepatitis B core antibody positive graft: a case report"],"prefix":"10.1186","volume":"2","author":[{"given":"Yasuyuki","family":"Hara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Tokodai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikashi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehito","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kawagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,28]]},"reference":[{"key":"246_CR1","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1053\/gast.1997.v113.pm9352871","volume":"113","author":"RC Dickson","year":"1997","unstructured":"Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. 1997;113:1668\u201374.","journal-title":"Gastroenterology"},{"key":"246_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/jlts.2001.20786","volume":"7","author":"M Prieto","year":"2001","unstructured":"Prieto M, Gomez MD, Berenguer M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl. 2001;7:51\u20138.","journal-title":"Liver Transpl"},{"key":"246_CR3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-6143.2003.00063.x","volume":"3","author":"GV Papatheodoridis","year":"2003","unstructured":"Papatheodoridis GV, Sevastianos V, Burroughs AK. Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era. Am J Transplant. 2003;3:250\u20138.","journal-title":"Am J Transplant"},{"key":"246_CR4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/jhep.2000.19789","volume":"32","author":"D Shouval","year":"2000","unstructured":"Shouval D, Samuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review. Hepatology. 2000;32:1189\u201395.","journal-title":"Hepatology"},{"key":"246_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65\u201373.","journal-title":"JAMA"},{"key":"246_CR6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","volume":"58","author":"MH Lee","year":"2013","unstructured":"Lee MH, Yang HI, Liu J, et al. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology. 2013;58:546\u201354.","journal-title":"Hepatology"},{"key":"246_CR7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","volume":"354","author":"TT Chang","year":"2006","unstructured":"Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354:1001\u201310.","journal-title":"N Engl J Med"},{"key":"246_CR8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","volume":"52","author":"TT Chang","year":"2010","unstructured":"Chang TT, Liaw YF, Wu SS, et al. Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52:886\u201393.","journal-title":"Hepatology"},{"key":"246_CR9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468\u201375.","journal-title":"Lancet"},{"key":"246_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"EASL clinical practice guidelines","year":"2012","unstructured":"EASL clinical practice guidelines. Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167.","journal-title":"J Hepatol"},{"key":"246_CR11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2893.2009.01146.x","volume":"17","author":"RG Gish","year":"2010","unstructured":"Gish RG, Chang TT, Lai CL, et al. Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B. J Viral Hepat. 2010;17:16\u201322.","journal-title":"J Viral Hepat"},{"key":"246_CR12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","volume":"140","author":"EJ Heathcote","year":"2011","unstructured":"Heathcote EJ, Marcellin P, Buti M, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011;140:132\u201343.","journal-title":"Gastroenterology"},{"key":"246_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1620\/tjem.222.275","volume":"222","author":"N Kawagishi","year":"2010","unstructured":"Kawagishi N, Takeda I, Miyagi S, et al. Nucleoside analogue therapy following one-year course of hepatitis B immunoglobulin in preventing hepatitis B virus reactivation after living donor liver transplantation. Tohoku J Exp Med. 2010;222:275\u20139.","journal-title":"Tohoku J Exp Med"},{"key":"246_CR14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1440-1843.2010.01822.x","volume":"15","author":"CL Lai","year":"2010","unstructured":"Lai CL, Yuen MF. Systemic corticosteroid and reactivation of chronic hepatitis B. Respirology. 2010;15:1017\u20138.","journal-title":"Respirology"},{"key":"246_CR15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.humimm.2014.09.006","volume":"75","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y, Ohira M, Tashiro H, Imamura M, Chayama K, Ohdan H. Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipients. Hum Immunol. 2014;75:1259\u201367.","journal-title":"Hum Immunol"},{"key":"246_CR16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cgh.2007.09.005","volume":"5","author":"HL Chan","year":"2007","unstructured":"Chan HL, Wong VW, Tse AM, et al. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol. 2007;5:1462\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"246_CR17","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","volume":"51","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology. 2010;51:1933\u201344.","journal-title":"Hepatology"},{"key":"246_CR18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.1840180605","volume":"18","author":"TL Fong","year":"1993","unstructured":"Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology. 1993;18:1313\u20138.","journal-title":"Hepatology"},{"key":"246_CR19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","volume":"2","author":"B Rehermann","year":"1996","unstructured":"Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996;2:1104\u20138.","journal-title":"Nat Med"},{"key":"246_CR20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1872-034X.2007.00094.x","volume":"37","author":"A Matsumoto","year":"2007","unstructured":"Matsumoto A, Tanaka E, Minami M, et al. Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy. Hepatol Res. 2007;37:661\u20136.","journal-title":"Hepatol Res"},{"key":"246_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1872-034X.2011.00910.x","volume":"42","author":"A Matsumoto","year":"2012","unstructured":"Matsumoto A, Tanaka E, Suzuki Y, et al. Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B. Hepatol Res. 2012;42:139\u201349.","journal-title":"Hepatol Res"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-016-0246-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-016-0246-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-016-0246-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:17:20Z","timestamp":1498342640000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-016-0246-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1186\/s40792-016-0246-2","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,28]]},"article-number":"118"}}